ID,CONSIDERATION,DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
T37-062-RT,major,"Antidepressants -other",Mirtazapine,"CYP2D6CYP1A2",Reduced / inadequate response,-
T37-062-RT,major,"Antidepressants -serotoninnoradrenalinereuptake inhibitors",Duloxetine,"CYP2D6CYP1A2",Reduced / inadequate response,-
T37-062-RT,major,,Venlafaxine,CYP2D6,Altered response,DPWG2
T37-062-RT,major,"Antidepressants -SSRIs",Citalopram,CYP2C19,Reduced / inadequate response,CPIC1
T37-062-RT,major,,Escitalopram,CYP2C19,Reduced / inadequate response,CPIC1
T37-062-RT,major,,Fluvoxamine,"CYP2D6CYP1A2",Reduced / inadequate response,CPIC1
T37-062-RT,major,,Paroxetine,CYP2D6,Reduced / inadequate response,CPIC1
T37-062-RT,major,"Antidepressants -tricyclicantidepressants",Amitriptyline,"CYP2D6CYP2C19",Reduced / inadequate response,CPIC3
T37-062-RT,major,,Clomipramine,"CYP2D6CYP2C19",Reduced / inadequate response,CPIC3
T37-062-RT,major,,Desipramine,CYP2D6,Reduced / inadequate response,CPIC3
T37-062-RT,major,,Doxepin,"CYP2D6CYP2C19",Reduced / inadequate response,CPIC3
T37-062-RT,major,,Imipramine,"CYP2D6CYP2C19",Reduced / inadequate response,CPIC3
T37-062-RT,major,,Nortriptyline,CYP2D6,Reduced / inadequate response,CPIC3
T37-062-RT,major,Antiemetics,Ondansetron,CYP2D6,Reduced / inadequate response,CPIC4
T37-062-RT,major,Antifungals - Azoles,Voriconazole,CYP2C19,Reduced / inadequate response,CPIC5
T37-062-RT,major,Beta blockers,Metoprolol,CYP2D6,Reduced / inadequate response,DPWG2
T37-062-RT,major,Miscellaneous,Eliglustat,CYP2D6,Reduced / inadequate response,TGA6
T37-062-RT,major,Opioid Analgesics,Codeine,"CYP2D6OPRM1",Adverse effects,CPIC7
T37-062-RT,major,,Hydrocodone,CYP2D6,Adverse effects,
T37-062-RT,major,,Oxycodone,CYP2D6,Adverse effects,DPWG2
T37-062-RT,major,,Tramadol,CYP2D6,Adverse effects,DPWG2
T37-062-RT,major,Statins,Simvastatin,"SLCO1B1CYP3A4","Increased therapeutic andadverse effects",CPIC8
T37-062-RT,minor,"ADHD -miscellaneous agents",Atomoxetine,CYP2D6,Reduced / inadequate response,-
T37-062-RT,minor,Antiarrhythmics,Flecainide,CYP2D6,Reduced / inadequate response,DPWG2
T37-062-RT,minor,,Propafenone,CYP2D6,Reduced / inadequate response,DPWG2
T37-062-RT,minor,"Anticholinergics(genitourinary)",Darifenacin,CYP2D6,Reduced / inadequate response,-
T37-062-RT,minor,,Fesoterodine,CYP2D6,Reduced / inadequate response,-
T37-062-RT,minor,,Tolterodine,CYP2D6,Reduced / inadequate response,-
T37-062-RT,minor,Anticholinesterases,Donepezil,CYP2D6,Reduced / inadequate response,-
T37-062-RT,minor,,Galantamine,CYP2D6,Reduced / inadequate response,-
T37-062-RT,minor,"Antidepressants -other",Moclobemide,CYP2C19,Reduced / inadequate response,-
T37-062-RT,minor,,Vortioxetine,CYP2D6,Reduced / inadequate response,-
T37-062-RT,minor,"Antidepressants -SSRIs",Fluoxetine,"CYP2D6CYP2C9",Altered response,-
T37-062-RT,minor,,Sertraline,CYP2C19,Reduced / inadequate response,CPIC1
T37-062-RT,minor,Antidiabetics,Gliclazide,"CYP2C9CYP2C19",Reduced / inadequate response,-
T37-062-RT,minor,Antiemetics,Metoclopramide,CYP2D6,Reduced / inadequate response,-
T37-062-RT,minor,Antihistamines,Chlorpheniramine,CYP2D6,Altered response,-
T37-062-RT,minor,,Dexchlorpheniramine,CYP2D6,Altered response,-
T37-062-RT,minor,,Promethazine,CYP2D6,Reduced / inadequate response,-
T37-062-RT,minor,Antiplatelet drugs,Clopidogrel,CYP2C19,Adverse effects,CPIC9
T37-062-RT,minor,Antipsychotics,Aripiprazole,CYP2D6,Reduced / inadequate response,-
T37-062-RT,minor,,Brexpiprazole,CYP2D6,Reduced / inadequate response,-
T37-062-RT,minor,,Chlorpromazine,CYP2D6,Reduced / inadequate response,-
T37-062-RT,minor,,Clozapine,CYP1A2,Reduced / inadequate response,-
T37-062-RT,minor,,Haloperidol,CYP2D6,Reduced / inadequate response,DPWG
T37-062-RT,minor,,Olanzapine,CYP1A2,Reduced / inadequate response,-
T37-062-RT,minor,,Pimozide,CYP2D6,Reduced / inadequate response,
T37-062-RT,minor,,Quetiapine,CYP3A4,Adverse effects,-
T37-062-RT,minor,,Risperidone,CYP2D6,Altered response,DPWG2
T37-062-RT,minor,,Zuclopenthixol,CYP2D6,Reduced / inadequate response,DPWG2
T37-062-RT,minor,Antitussives,Dextromethorphan,CYP2D6,Altered response,-
T37-062-RT,minor,Benzodiazepines,Clobazam,CYP2C19,Reduced / inadequate response,-
T37-062-RT,minor,,Diazepam,CYP2C19,Reduced / inadequate response,-
T37-062-RT,minor,Beta blockers,Carvedilol,CYP2D6,Reduced / inadequate response,-
T37-062-RT,minor,,Nebivolol,CYP2D6,Reduced / inadequate response,-
T37-062-RT,minor,,Propranolol,"CYP2D6CYP1A2",Altered response,-
T37-062-RT,minor,Hypnotics,Melatonin,CYP1A2,Reduced / inadequate response,-
T37-062-RT,minor,"Immunomodulatorsand antineoplastics",Tamoxifen,CYP2D6,"Increased therapeutic and/oradverse effects",CPIC10
T37-062-RT,minor,Miscellaneous,Cyclophosphamide,CYP2C19,"Increased therapeutic and/oradverse effects",-
T37-062-RT,minor,,Naltrexone,OPRM1,"Associated with reducedresponse to naltrexone",
T37-062-RT,minor,,Proguanil,CYP2C19,Altered response,-
T37-062-RT,minor,Neurological drugs,Tetrabenazine,CYP2D6,Reduced / inadequate response,-
T37-062-RT,minor,Opioid Analgesics,Morphine,OPRM1,"Associated with increasedtherapeutic and/or adverseeffects to morphine",-
T37-062-RT,minor,"Proton pumpinhibitors",Dexlansoprazole,CYP2C19,Reduced / inadequate response,-
T37-062-RT,minor,,Esomeprazole,CYP2C19,Reduced / inadequate response,-
T37-062-RT,minor,,Lansoprazole,CYP2C19,Reduced / inadequate response,-
T37-062-RT,minor,,Omeprazole,CYP2C19,Reduced / inadequate response,-
T37-062-RT,minor,,Pantoprazole,CYP2C19,Reduced / inadequate response,-
T37-062-RT,minor,,Rabeprazole,CYP2C19,Reduced / inadequate response,-
T37-062-RT,minor,Psychostimulants,Dextroamphetamine,CYP2D6,Reduced / inadequate response,-
T37-062-RT,minor,,Lisdexamfetamine,CYP2D6,Reduced / inadequate response,-
T37-062-RT,minor,Statins,Atorvastatin,"SLCO1B1CYP3A4","Increased therapeutic andadverse effects",-
T37-062-RT,usual,"Angiotensin receptorblockers",Irbesartan,CYP2C9,"No altered effect predicted bygenotype",-
T37-062-RT,usual,,Losartan,CYP2C9,"No altered effect predicted bygenotype",-
T37-062-RT,usual,Anticoagulants,Acenocoumarol,"VKORC1CYP2C9",Normal acenocoumarol sensitivity,
T37-062-RT,usual,,Warfarin,"VKORC1CYP2C9",Normal warfarin sensitivity,FDA11
T37-062-RT,usual,Antidiabetics,Glimepiride,CYP2C9,"No altered effect predicted bygenotype",-
T37-062-RT,usual,,Glyburide,CYP2C9,"No altered effect predicted bygenotype",-
T37-062-RT,usual,Antiepileptics,Phenytoin,CYP2C9,"No altered effect predicted bygenotype",CPIC12
T37-062-RT,usual,Calcineurin inhibitors,Tacrolimus,CYP3A5,"No altered effect predicted bygenotype",CPIC13
T37-062-RT,usual,"Glaucoma - ocularpreparations",Timolol,CYP2D6,"No altered effect predicted bygenotype",-
T37-062-RT,usual,Miscellaneous,Atazanavir,CYP3A5,"No altered effect predicted bygenotype",-
T37-062-RT,usual,NSAIDs,Celecoxib,CYP2C9,"No altered effect predicted bygenotype",-
T37-062-RT,usual,,Diclofenac,CYP2C9,"No altered effect predicted bygenotype",-
T37-062-RT,usual,,Flurbiprofen,CYP2C9,"No altered effect predicted bygenotype",-
T37-062-RT,usual,,Ibuprofen,CYP2C9,"No altered effect predicted bygenotype",-
T37-062-RT,usual,,Indomethacin,CYP2C9,"No altered effect predicted bygenotype",-
T37-062-RT,usual,,Mefenamic Acid,CYP2C9,"No altered effect predicted bygenotype",-
T37-062-RT,usual,,Meloxicam,CYP2C9,"No altered effect predicted bygenotype",-
T37-062-RT,usual,,Piroxicam,CYP2C9,"No altered effect predicted bygenotype",-
T37-062-RT,usual,Statins,Fluvastatin,"SLCO1B1CYP2C9","No altered effect predicted bygenotype",-
T37-062-RT,usual,,Pravastatin,SLCO1B1,"No altered effect predicted bygenotype",-
T37-062-RT,usual,,Rosuvastatin,SLCO1B1,"No altered effect predicted bygenotype",-
